Summary

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 continues nearly 18 months later to present significant challenges to health systems and public health in both hemispheres, as well as the economies of every country. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed many hospitals and clinics and continue to do so in many countries. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health. This entry collection aims to gather diverse fields about COVID-19, including in epidemiology, public health, medicine, genetics, systems biology, informatics, data science, engineering, sociology, anthropology, nursing, environmental studies, statistics, and psychology.

Expand All
Entries
Topic Review
Baricitinib in COVID-19 Therapy
During the current pandemic, the vast majority of COVID-19 patients experienced mild symptoms, but some had a potentially fatal aberrant hyperinflammatory immune reaction characterized by high levels of IL-6 and other cytokines. Modulation of this immune reaction has proven to be the only method of reducing mortality in severe and critical COVID-19. The anti-inflammatory drug baricitinib (Olumiant) has recently been strongly recommended by the WHO for use in COVID-19 patients because it reduces the risk of progressive disease and death. It is a Janus Kinase (JAK) 1/2 inhibitor approved for rheumatoid arthritis which was suggested in early 2020 as a treatment for COVID-19.
  • 495
  • 01 Jul 2022
Topic Review
SARS-CoV-2 and Oral Health
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Wuhan, China, was first reported to the China Ministry of Health and the World Health Organization (WHO), on 31 December 2019. These initial cases were linked to an animal wet market. The SARS-CoV-2 and its virulent variants cause coronavirus disease 2019 (COVID-19), which is highly contagious and spreads rapidly. The WHO declared it a global emergency on 30 January 2020, and a global pandemic on 11 March 2020. The SARS-CoV-2 genome was identified to be 70–80% identical to the severe acute respiratory syndrome coronavirus (SARS-CoV) and several bat coronaviruses. The similarity between these coronaviruses suggests that the bat may be the natural host and potential reservoir for SARS-CoV-2, which may have been inadvertently transmitted to humans. SARS-CoV-2 transmits readily via droplet transmission; other modes of transmission may include aerosol and oral-fecal routes. It can also be transmitted via contact with infected surfaces and oral fluids. This puts dentists and healthcare professionals at risk of COVID-19 infections, and highlights dental and medical offices as a main risk setting for cross infection of patients and healthcare professionals. Mask, face shields, handwashing, and personal protective equipment (PPE) are currently used in dental and medical facilities for COVID-19 prevention consistent with CDC guidelines.
  • 408
  • 01 Jul 2022
Topic Review
Detection Techniques of SARS-CoV-2
The SARS-CoV-2 coronavirus, also known as the disease-causing agent for COVID-19, is a virulent pathogen that may infect people and certain animals. The global spread of COVID-19 and its emerging variation necessitates the development of rapid, reliable, simple, and low-cost diagnostic tools. Many methodologies and devices have been developed for the highly sensitive, selective, cost-effective, and rapid diagnosis of COVID-19. The diagnosis platforms into four groups: imaging, molecular-based detection, serological testing, and biosensors was organized. Each platform’s principle, advancement, utilization, and challenges for monitoring SARS-CoV-2 are discussed in detail. In addition, an overview of the impact of variants on detection, commercially available kits, and readout signal analysis has been presented. This would expand our understanding of developing advanced diagnostic approaches to evolve into susceptible, precise, and reproducible technologies to combat any future outbreak.
  • 374
  • 30 Jun 2022
Topic Review
Perceived Risk of COVID-19 and Employee Decision-Making
COVID-19 has negatively affected public health, crippled economies, and transformed social and business environments across the globe. The pandemic has intensified the precariousness of work and the challenge of managing employee performance. There is a convincing need for organizations to develop strong and supportive management and leadership systems, particularly for frontline workers given their atypical and straining work conditions. To do so, it is prudent for managers to continuously interact and engage with these employees to offer emotional support and encouragement, address any issues of concern, and demonstrate care for these workers and their families. 
  • 627
  • 01 Jul 2022
Topic Review
Marine Resources for the Omicron SARS-CoV-2 Variant
In November of 2021, a recently evolved variant of SARS-CoV-2, omicron, was discovered. In just one month, omicron has spread to more than 89 countries resulting in a rapid rise in cases and a new wave of infections. With over 46 mutations, omicron brings concern to the public health and may be able to infect at a greater capacity than previous strains. Although able to infect double vaccinated and previously infected individuals, the booster vaccine may prove promising. However, more research is needed to fully elucidate the key function of each mutation and to better develop effective drugs. Marine resources may be a promising drug discovery avenue to investigate. Through viral entry blockade and preventing viral replication and protein synthesis, metabolites produced from marine organisms may be promising against the evolving SARS-CoV-2.
  • 459
  • 29 Jun 2022
Topic Review
Sustainable Development Goals in the COVID-19 Pandemic
The Sustainable Development Goals are a global call to action to end poverty, close the gender gap, protect the planet, and improve the lives of people around the world. In 2015, the United Nations General Assembly adopted 17 goals as part of the 2030 Agenda for Sustainable Development, which sets out a plan to achieve the goals in 15 years. However, the COVID-19 pandemic crisis has been a turning point in the achievement of these goals, due to all its consequences at the political, economic, and socio-cultural levels.
  • 744
  • 28 Jun 2022
Topic Review
Association between Air Pollutant and COVID-19 Confirmed Cases
The COVID-19 pandemic raises awareness of how the fatal spreading of infectious disease impacts economic, political, and cultural sectors, which causes social implications. Across the world, strategies aimed at quickly recognizing risk factors have also helped shape public health guidelines and direct resources; however, they are challenging to analyze and predict since those events still happen. 
  • 465
  • 28 Jun 2022
Topic Review
Resistance Training for People with COVID-19
Among different physical exercise models that might help to prevent and treat COVID-19-related conditions, resistance training (RT) might be particularly relevant. Among its benefits, RT can be adapted to be performed in many different situations, even with limited space and equipment, and is easily adapted to an individual’s characteristics and health status.
  • 387
  • 28 Jun 2022
Topic Review
Motivations of Young Women Volunteers during COVID-19
Volunteering work has played a major role in dealing with the COVID-19 pandemic crisis.  In addition to personal, motivators behind the act of volunteering, with a greater dominance of normative motivations such as the call of the homeland and philanthropy. The influence of the collectivist culture in shaping the normative motivations behind volunteering among these women was visible, and there was also an influence of religion and religious values.
  • 472
  • 27 Jun 2022
Topic Review
COVID-19 Diagnosis
The world is grappling with the coronavirus disease 2019 (COVID-19) pandemic, the causative agent of which is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 symptoms are similar to the common cold, including fever, sore throat, cough, muscle and chest pain, brain fog, dyspnoea, anosmia, ageusia, and headache.
  • 1.2K
  • 27 Jun 2022
  • Page
  • of
  • 74

Featured Entry Collections

>>